// App-Quantinova.ai

2863 : Serum Proteomic Signatures Predict Relapse in Rheumatoid Arthritis Patients Undergoing DMARD Withdrawal

Researchers

Presenter

  • Liam O'Neil

Principal Investigators

  • Victor Spicer

  • Carol A Hitchon

  • Juergen Rech

  • Axel J. Hueber

  • John Wilkins

  • Hani El-Gabalawy

  • Georg Schett

Medical Centers

  • Physiology, University of Manitoba, Winnipeg, Canada

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Department of Internal Medicine 3 – Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany., Erlangen, Germany

  • Department of Internal Medicine , Rheumatology & Immunology, University of Erlangen-Nuremberg, Erlangen, Germany

Locations

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved